The 3D printed drugs market was valued at US$ 28.52million in 2019 and is expected to grow at a CAGR of 9.1% from 2020to 2027 to reach US$57.03million by 2027.
The 3D printed drugs market was valued at US$ 28.52million in 2019 and is expected to grow at a CAGR of 9.1% from 2020to 2027 to reach US$57.03million by 2027.
3D printed drugs are medications, which are designed by 3D printing technique to customize for the individuals in a safer and effective way. These drugs have unitary porous structures that readily disperse in the mouth, because of which these high-dose medicines need not to be swallowed intact. The main idea behind 3D printing drugs is to design and develop medicines that are suited to an individual's needs. The global 3D printed drugs market is driven by factors such as increasing adoption of personalized drugs. Additionally, growing research and development activities, coupled with increasing prevalence of dysphagia, is also anticipated to drive the 3D market growth during the forecast period. However, the usage of 3D printing to develop illegal drugs restrains the growth of the market. The developing healthcare infrastructure and increasing awareness regarding 3D printing in pharmaceuticals generate lucrative opportunities for the growth of the market.
Request for Sample of 3D Printed Drugs Market to know which pharma-biotech company is expected to be at the forefront in the coming years @ https://www.theinsightpartners.com/sample/TIPRE00010199/
Some of the Prominent/Emerging Players in 3D Printed Drugs Market:
Leading companies operating in the 3D printed drugs market are Aprecia Pharmaceuticals, LLC, FabRx Ltd, Cycle Pharmaceuticals, GlaxoSmithKline PLC., Astrazeneca, Tvasta, and Merck KGGA, among others.
Key Questions regarding Current 3D Printed Drugs Market Landscape
- What are the current options for 3D Printed Drugs Market?
- How many companies are developing for the 3D Printed Drugs Market?
- What are the key collaborations (Industry-Industry, Industry-Academia), Mergers and acquisitions, and significant licensing activities that will impact the 3D Printed Drugs market?
- Which are the dormant and discontinued products and the reasons for the same?
- What is the unmet need for current 3D Printed Drugs Market?
- What are the current novel therapies, targets, mechanisms of action, and technologies developed to overcome the limitation of existing 3D Printed Drugs?
- What are the critical designations that have been granted for 3D Printed Drugs Market?
3D printing offers the possibility of creating a personalized medicine system through automated control over drug dose and is suitable for both low and high drug concentrations. These advantages allow drug companies to not only boost efficacy and adherence, but also contribute to their brand longevity by expanding and capturing market share with other dosage forms. Through this breakthrough method of manufacturing and its fast-melt capabilities, there is an ability to overcome several obstacles, thereby contributing to better patient outcomes in the solid dose market. For instance, FabRx Ltd. completed the world’s first in-human clinical study using their proprietary Printlets technology, which relies on personalized 3D printed dosage forms to treat children with a rare metabolic disease. Additionally, the same company launched the first pharmaceutical 3D printer, M3DIMAKER, for the manufacture of personalized medicines in April 2020. Hence, there is a need for new manufacturing systems to prepare personalized medicines, and this potential application of 3D printing for rare diseases is countless. It could help make the medication safer and more attractive to children, thereby propelling the growth of the 3D printed drugs market.
The global 3D printed drugs market, based on the dosage forms, is segmented into tablets, capsules, multi drug implant, nanoparticles, solutions, and other dosage forms. The tablet segment held the largest share of the market in 2019, and it is further estimated to register the highest CAGR during the forecast period. The growth of the 3D printed drugs market is ascribed to the growing emphasis on personalized medicines and extensive R&D activities.
The 3D printed drugs market players also adopt the strategy of collaborations, which enables them enlarge their global customer base, alongside helping them maintain their brand names.
3D Printed Drugs Market – By Dosage Forms
- Tablets
- Capsules
- Multi Drug Implants
- Nanoparticles
- Solutions
- Others
3D Printed Drugs Market – By Technology
- Inkjet Printing
- Direct Write
- Zip Dose
- Thermal Inkjet Printing
- Fused Deposition Modeling
- Powder Bed Printing
- Stereolithography (SLA)
- Semi Solid Extrusion (SSE)
Interested in Purchasing this Report? Click here @ https://www.theinsightpartners.com/buy/TIPRE00010199/
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense, Food & beverage, Chemical and Materials, Semiconductors. Etc.
Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com